Stock Events

Collegium Pharmaceutical 

$32.15
23
+$0.33+1.04% Tuesday 20:00

Statistics

Day High
32.19
Day Low
31.28
52W High
40.95
52W Low
20.83
Volume
854,826
Avg. Volume
447,695
Mkt Cap
1.05B
P/E Ratio
15.02
Dividend Yield
-
Dividend
-

Earnings

9MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.14
0.43
1.01
1.58
Expected EPS
0.75
Actual EPS
1.45

People Also Follow

This list is based on the watchlists of people on Stock Events who follow COLL. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Analyst Ratings

41$Average Price Target
The highest estimate is $44.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

About

Health Technology
Pharmaceuticals: Other
Manufacturing
Pharmaceutical Preparation Manufacturing
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Show more...
CEO
Joseph Ciaffoni
Employees
197
Country
US
ISIN
US19459J1043
WKN
000A14SUV

Listings